Death Number Perception in Depression Anxiety and Schizoypal Personnality in General Population (Covid-19 Pandemic)

  • STATUS
    Recruiting
  • participants needed
    1000
  • sponsor
    University Hospital, Montpellier
Updated on 19 February 2024
anxiety
depression
delusions
covid-19
delusion

Summary

France has been put on a lockdown for 8 weeks to prevent the spread of the COVID-19 virus between 17/03/2020 and 11/05/2020. During this lockdown, which is likely to have psychopathological repercussions on the population, the public authorities and the media informed the population about the number of deaths occurring each day. While the functioning of autobiographical memory following traumatic events remains a debate in the literature, the impact of the daily announcement of mass deaths on the memory system in the general population and the relationship between long-term memory and delusional thinking in certain psychopathologies have yet to be explored in the literature.

The investigators wish to demonstrate that self-reported recall of recorded deaths may represent this distortion of perception, symptomatic of these pathologies by an on-line questionnaire.

Description

Indeed, it has been reported that under continued stress, delusions and psychotic experiences can occur in the general population. This phenomenon is found in individuals suffering from depression and anxiety and schizotypal personality disorder.

The investigators wish to demonstrate that self-reported recall of recorded deaths may represent this distortion of perception, symptomatic of these pathologies.

Thus, using an online longitudinal questionnaire, the investigators wish to explore :

  • how the memory system is impacted by mass deaths over several trimesters in the general population.
  • whether the long-term memory of people suffering from depression and anxiety disorders and people suffering from schizotypal personality disorder contains recollection of a distorted pattern in relation to the actual number of deaths.

Primary goals of this project are:

Determine, in the context of mass deaths, the level and proportion of real or conceived recall of the number of deaths in the general population based on cognitive and affective empathy profiles over four trimesters.

Also the investigators want to determine

  • the proportion of real or conceived recall numbers of deaths by COVID-19 among people suffering from depression and anxiety in a context of mass death.
  • the proportion of real or conceived recall number of deaths by COVID-19 among people with schizotypal personality disorder.
  • the dynamics of this real or conceived recall for four trimester following the end of lockdown.
    Methodology

The entire study will be conducted online. Participants will provide their informed consent. At these assessment, they will provide a set of self report measures associated to COVID-19 related psychological aspects especially for depression, anxiety and schizotypal personality.

Subjects can only participate once.

Sample size:

There is no minimum/maximum sample size for this study. The study will remain open for 1 year. The sample size should reach 1000 participants at least.

List of self-report measures:

  • Brief Trauma Questionnaire (BTQ)
  • COVID-Related Thoughts and Behavioral Symptoms (COV-TaBS)
  • Beck Depression Inventory (BDI)
  • State and Trait Anxiety Inventory (STAI)
  • The Hospital Anxiety and Depression Scale (HAPS)
  • Questionnaire of Cognitive and Affective Empathy (QCAE)
  • Raine Schizotypal Personality Questionnaire, (SPQ)
  • Paranoia Scale

Details
Condition Psychosis, Psychosis, Mental illness, General Population
Age 18-100 years
Clinical Study IdentifierNCT04384419
SponsorUniversity Hospital, Montpellier
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Individuals from the general population
French native speacker
Majority 18 years and more

Exclusion Criteria

Patient refusing to participate in research
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.